CERKALIS BIO Trademark Information
Number:
2678874
Words:
CERKALIS BIO
Kind:
Word
Status group:
PENDING
Status code:
Published
Status detail:
Awaiting examination
Priority date:
21 Jul 2026
Lodgement date:
21 Jul 2026
Filing date:
21 Jul 2026
Indexing constituents:
CERKALIS, BIOClass:
5,42
Mark categories:
Trademark
Last status check:
2026-07-24 17:05:40
Goods and services:
1) Class: 5Description: Pharmaceutical, medicinal and therapeutic preparations for human and veterinary use; pharmaceutical and therapeutic preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases and genetic disorders; pharmaceutical products and preparations; medicinal preparations and substances; diagnostic agents, preparations and substances for medical purposes; chemical preparations for pharmaceutical use; biological preparations for medical purposes; biologics for medical purposes; biologics for the treatment of cancer, autoimmune and chronic diseases; biotechnological preparations for medical purposes; vaccines; reagents for medical purposes; bispecific small molecules that mediate targeted protein degradation through the ubiquitin proteasome system for medical purposes; pharmaceutical and therapeutic preparations for modulating protein degradation pathways; pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases and genetic disorders
2) Class: 42
Description: Research, design and development services; scientific and medical research and development; product research and development; pharmaceutical research and development; biotechnology research and development; biological, clinical and medical research; industrial research, development and testing services; scientific and technological services; scientific research; clinical trials; laboratory research and analysis; chemical and biochemical analysis services; provision of information and data relating to scientific and technological research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in the field of scientific research and biotechnology; design and development of medical technology; analysis of technical data; research and development in the field of small molecule therapeutics; research and development in the field of targeted protein degrader drugs; drug discovery, pharmaceutical drug development, and drug validation services in the field of targeted disease-causing or disease-associated protein degradation; medical and pharmaceutical research services in relation to protein degradation; research and development of platform technology, namely, biotherapeutic platforms for use in manufacturing pharmaceuticals and therapeutics in the pharmaceutical and biotechnology fields
History and publication details:
1) Date: 2026-07-23
Display name: Awaiting examination
2) Date: 2026-07-21
Display name: IP Right Filed correspondence sent
3) Date: 2026-07-21
Display name: IP Right Filed Published
4) Date: 2026-07-21
Display name: Status change to Published
5) Date: 2026-07-21
Display name: Minimum Filing Requirements Considered
6) Date: 2026-07-21
Display name: Status change to Filed
7) Date: 2026-07-21
Display name: Status change to Received
8) Date: 2026-07-21
Display name: Trade mark representation updated
9) Date: 2026-07-21
Display name: Application Received
Display name: Awaiting examination
2) Date: 2026-07-21
Display name: IP Right Filed correspondence sent
3) Date: 2026-07-21
Display name: IP Right Filed Published
4) Date: 2026-07-21
Display name: Status change to Published
5) Date: 2026-07-21
Display name: Minimum Filing Requirements Considered
6) Date: 2026-07-21
Display name: Status change to Filed
7) Date: 2026-07-21
Display name: Status change to Received
8) Date: 2026-07-21
Display name: Trade mark representation updated
9) Date: 2026-07-21
Display name: Application Received
Owner Information
Owner Abn:
88666622957
Owner structured address:
Level 11, 655 Elizabeth Street, Melbourne, VIC, AUSTRALIA, Postal Code: 3000
Owner is private:
0
Service Information
Address structured address:
GPO Box 9938, Melbourne, VIC, AUSTRALIA, Postal Code: 3001
Address is private:
0